Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The poliovirus type 1 capsid protein (Sabin strain) is a structural protein component of the attenuated type 1 poliovirus used in the oral polio vaccine (OPV). The Sabin strains are live, weakened forms of wild-type polioviruses, developed to induce immunity without causing disease. The capsid proteins form the outer shell of the virus particle and are critical for its infectivity, antigenicity, and interaction with host cell receptors. It is not a therapeutic target, it is a viral protein.
The oral poliovirus vaccine (OPV) utilizes the Sabin strain to induce an immune response against the poliovirus. The capsid protein elicits antibody production, neutralizing the virus and preventing infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus Type 1 Capsid Protein (Sabin Strain).